1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Catherine Spina: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer Quemliclustat, Etrumadenant, Zimberelimab - Oligometastatic Prostate Cancer | Phase 2 | Recruiting | Catherine Spina | 23 | 2023-07-01 | 2025-05-20 |
Radiosurgery (1) · quemliclustat (1) · zimberelimab (1)
United States (1)